Oppenheimer Holdings Inc. restated their outperform rating on shares of Imperva Inc. (NYSE:IMPV) in a research report sent to investors on Friday. They currently have a $60.00 price target on the stock.
IMPV has been the subject of a number of other research reports. Wunderlich assumed coverage on Imperva in a research note on Tuesday, September 13th. They set a hold rating and a $50.00 price target for the company. Pacific Crest downgraded Imperva from an overweight rating to a sector weight rating and cut their price target for the company from $47.00 to $30.00 in a research note on Tuesday, August 30th. BTIG Research reiterated a buy rating and set a $55.00 price target on shares of Imperva in a research note on Tuesday, June 21st. Needham & Company LLC reiterated a hold rating on shares of Imperva in a research note on Tuesday, June 21st. Finally, Morgan Stanley reiterated a sell rating on shares of Imperva in a research note on Thursday, June 30th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and fourteen have assigned a buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $53.33.
Shares of Imperva (NYSE:IMPV) opened at 53.18 on Friday. Imperva has a 52-week low of $31.11 and a 52-week high of $77.99. The stock’s 50 day moving average price is $46.58 and its 200-day moving average price is $44.39. The company’s market cap is $1.73 billion.
Imperva (NYSE:IMPV) last issued its earnings results on Thursday, August 4th. The company reported ($0.23) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by $0.19. The firm earned $57.87 million during the quarter, compared to analyst estimates of $66.06 million. Imperva had a negative net margin of 23.75% and a negative return on equity of 25.68%. The business’s quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.08) earnings per share. Equities analysts expect that Imperva will post ($0.80) EPS for the current year.
In other Imperva news, SVP Mark E. Kraynak sold 5,582 shares of the business’s stock in a transaction on Friday, September 23rd. The shares were sold at an average price of $51.00, for a total transaction of $284,682.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Amichai Shulman sold 937 shares of the business’s stock in a transaction on Friday, September 23rd. The shares were sold at an average price of $51.00, for a total transaction of $47,787.00. Following the sale, the insider now directly owns 95,084 shares in the company, valued at approximately $4,849,284. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.
Large investors have recently modified their holdings of the stock. Tower Research Capital LLC TRC boosted its stake in shares of Imperva by 2,252.0% in the second quarter. Tower Research Capital LLC TRC now owns 2,352 shares of the company’s stock worth $101,000 after buying an additional 2,252 shares during the last quarter. Bank of Montreal Can acquired a new stake in shares of Imperva during the second quarter worth about $107,000. BlackRock Inc. boosted its stake in shares of Imperva by 37.1% in the second quarter. BlackRock Inc. now owns 2,596 shares of the company’s stock worth $111,000 after buying an additional 703 shares during the last quarter. Compagnie Lombard Odier SCmA acquired a new stake in shares of Imperva during the second quarter worth about $147,000. Finally, Teacher Retirement System of Texas boosted its stake in shares of Imperva by 13.7% in the second quarter. Teacher Retirement System of Texas now owns 3,975 shares of the company’s stock worth $171,000 after buying an additional 478 shares during the last quarter. 93.26% of the stock is currently owned by institutional investors and hedge funds.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.